COVID-19 antibody / Dyadic International, Israeli Institute for Biological Research - LARVOL DELTA

[VIRTUAL] Preliminary Data on the First Group of Convalescent COVID-19 Plasma Donors in Israel (AABB 2020) - "Centralizing CCP collection by the national blood services, enabled the rapid creation of a sufficient inventory and provided access to CCP as treatment to moderate and severe cases of COVID-19 nationwide Nearly 90% of the donors had IgG antibodies, and NA in titers of >1:160 were present in 86% of the serological positive donorsץFurther information will be gathered as we continue with CCP collection for treatment for COVID-19 patients and for the production of Hyper immune globulin in Israel."

Infectious Disease • Novel Coronavirus Disease